ENTITY
MicroPort CardioFlow

MicroPort CardioFlow (2160 HK)

63
Analysis
Health Care • China
MicroPort CardioFlow Medtech Corporation is a medical device company specializing in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases. Its product portfolio includes transcatheter aortic valves, left atrial appendage closure systems, and cardiac rhythm management devices like pacemakers and implantable cardioverter-defibrillators. The company was founded in 2015 and is headquartered in Shanghai, China.
more
•26 Jan 2021 17:18

MicroPort CardioFlow IPO: Valuation Insights

MicroPort aims to raise total net proceeds of $290 million at the mid-point of the IPO price range of HK$11.10-12.20 per share. Overall, we think...

Logo
480 Views
Share
•24 Jan 2021 10:20

MicroPort Cardioflow (å¾®åˆ›åæƒé€š) Pre-IPO: Thoughts on Valuation

We are taking a close look at the Microport Cardioflow’s valuation. We are of the view that the company’s fair value should be around USD 3.0 billion.

Logo
578 Views
Share
bullish•Kuaishou Technology
•24 Jan 2021 09:14

ECM Weekly (24 January 2021) - Kuaishou, New Horizon Health, Indigo Paints, Home First Fin, IRFC

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•21 Jan 2021 23:41

MicroPort CardioFlow: PHIP Updates and More on TMV

MicroPort CardioFlow plans an HKEX listing. This Insight discusses updated disclosures in its PHIP filing; developments in the TAVR market; the...

Share
•21 Jan 2021 18:57

Venus Medtech (åÆę˜ŽåŒ»ē–—) & Peijia Medical (ę²›å˜‰åŒ»ē–—) Placement - Take Your Pick

Venus MedTech (2500 HK) is looking to raise up to US$187m in its primary placement. At the same time, Peijia Medical (9996 HK) is looking to raise...

Share
x